Conformational sampling of CMT-2D associated GlyRS mutations.

Matthew Carter Childers1,2, Michael Regnier1,2, Mark Bothwell2,3

  • 1Department of Bioengineering, University of Washington, Seattle, WA, United States.

Brain Multiphysics
|December 12, 2022
PubMed
Summary

Molecular dynamics simulations reveal how mutations in glycyl-tRNA synthetase (GlyRS) disrupt protein synthesis and cause Charcot-Marie-Tooth disease type 2D (CMT-2D). The G240R mutation alters enzyme structure and dynamics, offering insights into disease mechanisms.

Related Concept Videos